These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30678966)

  • 21. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.
    Park H; Yang J; Lee J; Haam S; Choi IH; Yoo KH
    ACS Nano; 2009 Oct; 3(10):2919-26. PubMed ID: 19772302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxorubicin-conjugated CuS nanoparticles for efficient synergistic therapy triggered by near-infrared light.
    Bi H; Dai Y; Lv R; Zhong C; He F; Gai S; Gulzar A; Yang G; Yang P
    Dalton Trans; 2016 Mar; 45(12):5101-10. PubMed ID: 26883928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
    Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
    Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuning the In Vivo Transport of Anticancer Drugs Using Renal-Clearable Gold Nanoparticles.
    Peng C; Xu J; Yu M; Ning X; Huang Y; Du B; Hernandez E; Kapur P; Hsieh JT; Zheng J
    Angew Chem Int Ed Engl; 2019 Jun; 58(25):8479-8483. PubMed ID: 31006932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-Assembled Upconversion Nanoparticle Clusters for NIR-controlled Drug Release and Synergistic Therapy after Conjugation with Gold Nanoparticles.
    Cai H; Shen T; Kirillov AM; Zhang Y; Shan C; Li X; Liu W; Tang Y
    Inorg Chem; 2017 May; 56(9):5295-5304. PubMed ID: 28402112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective Killing of Breast Cancer Cells by Doxorubicin-Loaded Fluorescent Gold Nanoclusters: Confocal Microscopy and FRET.
    Chattoraj S; Amin A; Jana B; Mohapatra S; Ghosh S; Bhattacharyya K
    Chemphyschem; 2016 Jan; 17(2):253-9. PubMed ID: 26615975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical characterization and potential cancer therapy applications of hydrogel beads loaded with doxorubicin and GaOOH nanoparticles.
    Żmuda A; Kamińska W; Bartel M; Głowacka K; Chotkowski M; Medyńska K; Wiktorska K; Mazur M
    Sci Rep; 2024 Sep; 14(1):20822. PubMed ID: 39242631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assembled microcapsules by doxorubicin and polysaccharide as high effective anticancer drug carriers.
    Du C; Zhao J; Fei J; Cui Y; Li J
    Adv Healthc Mater; 2013 Sep; 2(9):1246-51. PubMed ID: 23554398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells.
    Minaei A; Sabzichi M; Ramezani F; Hamishehkar H; Samadi N
    Mol Biol Rep; 2016 Feb; 43(2):99-105. PubMed ID: 26748999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Green chemistry approach for the synthesis and stabilization of biocompatible gold nanoparticles and their potential applications in cancer therapy.
    Mukherjee S; Sushma V; Patra S; Barui AK; Bhadra MP; Sreedhar B; Patra CR
    Nanotechnology; 2012 Nov; 23(45):455103. PubMed ID: 23064012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and evaluation of clickable gelatin-oleic nanoparticles using fattigation-platform for cancer therapy.
    Meghani NM; Amin HH; Park C; Park JB; Cui JH; Cao QR; Lee BJ
    Int J Pharm; 2018 Jul; 545(1-2):101-112. PubMed ID: 29698822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.
    Azarmi S; Tao X; Chen H; Wang Z; Finlay WH; Löbenberg R; Roa WH
    Int J Pharm; 2006 Aug; 319(1-2):155-61. PubMed ID: 16713150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of multi-functionalized Fe3O4/Au nanoparticles for medical purposes.
    Ramos-Tejada MDM; Viota JL; Rudzka K; Delgado AV
    Colloids Surf B Biointerfaces; 2015 Apr; 128():1-7. PubMed ID: 25710633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gold nanorod-cored biodegradable micelles as a robust and remotely controllable doxorubicin release system for potent inhibition of drug-sensitive and -resistant cancer cells.
    Zhong Y; Wang C; Cheng L; Meng F; Zhong Z; Liu Z
    Biomacromolecules; 2013 Jul; 14(7):2411-9. PubMed ID: 23701318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A high local DNA concentration for nucleating a DNA/Fe coordination shell on gold nanoparticles.
    Huang Z; Liu B; Liu J
    Chem Commun (Camb); 2020 Apr; 56(30):4208-4211. PubMed ID: 32168370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymeric-gold nanohybrids for combined imaging and cancer therapy.
    Topete A; Alatorre-Meda M; Villar-Alvarez EM; Carregal-Romero S; Barbosa S; Parak WJ; Taboada P; Mosquera V
    Adv Healthc Mater; 2014 Aug; 3(8):1309-25. PubMed ID: 24764284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vitro assessment of novel chitosan/bimetallic PtAu nanocomposites as delivery vehicles for doxorubicin.
    Maney V; Singh M
    Nanomedicine (Lond); 2017 Nov; 12(21):2625-2640. PubMed ID: 28965478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu.
    Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM
    Mol Pharm; 2015 Nov; 12(11):3963-72. PubMed ID: 26402157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.